高级检索
当前位置: 首页 > 详情页

NPAS2 Contributes to Liver Fibrosis by Direct Transcriptional Activation of Hes1 in Hepatic Stellate Cells

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Fourth Mil Med Univ, Tangdu Hosp, Dept Pain Treatment, 1 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China [2]Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China [3]Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, Xian 710032, Shaanxi, Peoples R China [4]75 Grp Army Hosp, Dept Gen Surg, Dali 671000, Yunnan, Peoples R China [5]Zhengzhou Univ, Affiliated Hosp 1, Dept Gen Surg, Zhengzhou 450052, Henan, Peoples R China [6]Xi An Jiao Tong Univ, Coll & Hosp Stomatol, Xian 710004, Shaanxi, Peoples R China [7]Chongqing Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing 400016, Peoples R China [8]Xian Cent Hosp, Dept Hematol, Xian 710003, Shaanxi, Peoples R China [9]Shaanxi Prov Peoples Hosp, Dept Hepatobiliary Surg, 256 West Friendship Rd, Xian 710068, Shaanxi, Peoples R China
出处:
ISSN:

关键词: circadian gene hepatic stellate cell Hes1 liver fibrosis neuronal PAS domain protein 2

摘要:
Recently, emerging evidence shows that dysregulation of circadian genes is closely associated with liver fibrosis. However, how dysregulation of circadian genes promotes liver fibrosis is unknown. In this study, we show that neuronal PAS domain protein 2 (NPAS2), one of the core circadian molecules that has been shown to promote hepatocarcinoma cell proliferation, significantly contributed to liver fibrogenesis. NPAS2 is upregulated in hepatic stellate cells (HSCs) after fibrogenic injury, which subsequently contributes to the activation of HSCs. Mechanistically, NPAS2 plays a profibrotic role via direct transcriptional activation of hairy and enhancer of split 1 (Hes1), a critical transcriptor of Notch signaling for the fibrogenesis process, in HSCs. Our findings demonstrate that NPAS2 plays a critical role in liver fibrosis through direct transcriptional activation of Hes1, indicating that NPAS2 may serve as an important therapeutic target to reverse the progression of liver fibrosis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验
JCR分区:
出版当年[2018]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Fourth Mil Med Univ, Tangdu Hosp, Dept Pain Treatment, 1 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Fourth Mil Med Univ, Tangdu Hosp, Dept Pain Treatment, 1 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China [7]Chongqing Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing 400016, Peoples R China [8]Xian Cent Hosp, Dept Hematol, Xian 710003, Shaanxi, Peoples R China [9]Shaanxi Prov Peoples Hosp, Dept Hepatobiliary Surg, 256 West Friendship Rd, Xian 710068, Shaanxi, Peoples R China [*1]Department of Hepatobiliary Surgery, Shaanxi Provincial People’s Hospital, 256 West Friendship Road, Xi’an 710068, China [*2]Department of Pain Treatment, Tangdu Hospital, The Fourth Military Medical University, 1 Xinsi Road, Xi’an 710038, China [*3]Department of Hematology, Xi’an Central Hospital, Xi’an, Shaanxi 710003, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82478 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号